Skip to main content
Clinical Trials/JPRN-UMIN000038854
JPRN-UMIN000038854Not yet recruiting未知

albuphine versus Magnesium Sulfate as an Adjuvant in Infraclavicular Brachial Plexus Block - Infraclav, MgSo4,Nalbu,

Faculty of medicine, Menofia University, Egypt0 sites60 target enrollmentStarted: December 9, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
21years-old to 62years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • patient refusal, or uncooperative patients, patient on anticoagulant therapy evidence of sever pulmonary, hepatic or renal disease, body mass index more than 35kg/m2,and history of brachial plexus injury and allergy to any of the drugs that will be used in the study.

Investigators

Sponsor
Faculty of medicine, Menofia University, Egypt

Similar Trials